Journal
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY
Volume 15, Issue 2, Pages 71-72Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/nrgastro.2017.181
Keywords
-
Categories
Funding
- AbbVie
- Boehringer Ingelheim
- Gilead
- Intercept
- Janssen
- Novartis
- Novo Nordisk
- Pharmaxis
- Shire
- National Institute of Health Research
- National Institute for Health Research [ACF-2014-09-002] Funding Source: researchfish
Ask authors/readers for more resources
In 2017, there have been substantial advances in our understanding of the immunological and endocrine mechanisms of disease progression in NAFLD, paving the way for novel therapeutic strategies.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
